Invention Grant
- Patent Title: Deazapurines and uses thereof
- Patent Title (中): 脱氮嘌呤及其用途
-
Application No.: US10500840Application Date: 2003-01-07
-
Publication No.: US07314936B2Publication Date: 2008-01-01
- Inventor: Jane Daun , Heather A. Davis , Bruce DeCosta , Fabian Gusovsky , Ieharu Hishinuma , Yimin Jiang , Toshihiko Kaneko , Kouichi Kikuchi , Seiichi Kobayashi , André Lescarbeau , Xiang-Yi Li , Kenzo Muramoto , Norihito Ohi , Marc Pesant , Boris M. Seletsky , Motohiro Soejima , Mark Spyvee , Lynda Tremblay , Ye Yao , Hiromitsu Yokohama , Yan (Janet) Zhao , Wanjun Zheng
- Applicant: Jane Daun , Heather A. Davis , Bruce DeCosta , Fabian Gusovsky , Ieharu Hishinuma , Yimin Jiang , Toshihiko Kaneko , Kouichi Kikuchi , Seiichi Kobayashi , André Lescarbeau , Xiang-Yi Li , Kenzo Muramoto , Norihito Ohi , Marc Pesant , Boris M. Seletsky , Motohiro Soejima , Mark Spyvee , Lynda Tremblay , Ye Yao , Hiromitsu Yokohama , Yan (Janet) Zhao , Wanjun Zheng
- Applicant Address: JP Tokyo
- Assignee: Eisai Co., Ltd.
- Current Assignee: Eisai Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Myers Bigel Sibley & Sajovec, PA
- International Application: PCT/US03/00366 WO 20030107
- International Announcement: WO03/057696 WO 20030717
- Main IPC: C07D498/02
- IPC: C07D498/02 ; C07D513/02 ; C07D515/02 ; C07D471/02
Abstract:
The present invention provides compounds having formula (I), wherein R1, R2, R3 and n are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof in the treatment of inflammatory or autoimmune and proliferative disorders and as inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction generally
Public/Granted literature
- US20050124649A1 Deazapurines and uses thereof Public/Granted day:2005-06-09
Information query
